Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.

por Honkoop, A. H., Hoekman, K., Wagstaff, J., van Groeningen, C. J., Vermorken, J. B., Boven, E., Pinedo, H. M.
Publicado 1996

Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.

por Steyerberg, E. W., Keizer, H. J., Zwartendijk, J., Van Rijk, G. L., Van Groeningen, C. J., Habbema, J. D., Stoter, G.
Publicado 1993

In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.

por Peters, G. J., van Dijk, J., Laurensse, E., van Groeningen, C. J., Lankelma, J., Leyva, A., Nadal, J. C., Pinedo, H. M.
Publicado 1988

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule

por Boven, E, Westerman, M, van Groeningen, C J, Verschraagen, M, Ruijter, R, Zegers, I, van der Vijgh, W J F, Giaccone, G
Publicado 2005

The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study

por Bruynzeel, A M E, Niessen, H W M, Bronzwaer, J G F, van der Hoeven, J J M, Berkhof, J, Bast, A, van der Vijgh, W J F, van Groeningen, C J
Publicado 2007

Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer

por van Zweeden, A. A., van Groeningen, C. J., Honeywell, R. J., Giovannetti, E., Ruijter, R., Smorenburg, C. H., Giaccone, G., Verheul, H. M. W., Peters, G. J., van der Vliet, Hans J.
Publicado 2018